Quick Takeaways
- Douglas J. Manion has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $128,954.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Douglas J. Manion
- Location
- Wayne, PA
- Summary
- The estimated net worth of Douglas J. Manion is at least $128,954 dollars as of 03 Jan 2024. Douglas J. Manion is the Pres and CEO, Director of Aclaris Therapeutics, Inc. and owns shares of Aclaris Therapeutics, Inc. (ACRS) stock worth about $129K.
- Signature
- /s/ Mark Ballantyne, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Douglas J. Manion and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: Aclaris Therapeutics, Inc. ($128,954).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Douglas J. Manion
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Pres and CEO, Director | $128,954 | 01 Jan 2024 | ||
| ARNA | ARENA PHARMACEUTICALS INC | EVP Research & Development | 11 Mar 2022 |
Insider Transactions Reported by Douglas J. Manion:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.